Free Trial

Semler Scientific (SMLR) Competitors

Semler Scientific logo
$42.53 +0.35 (+0.83%)
As of 12:48 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

SMLR vs. CNMD, AORT, CDRE, ESTA, TNDM, FNA, BLFS, LQDA, SSII, and PLSE

Should you be buying Semler Scientific stock or one of its competitors? The main competitors of Semler Scientific include CONMED (CNMD), Artivion (AORT), Cadre (CDRE), Establishment Labs (ESTA), Tandem Diabetes Care (TNDM), Paragon 28 (FNA), BioLife Solutions (BLFS), Liquidia Technologies (LQDA), SS Innovations International (SSII), and Pulse Biosciences (PLSE). These companies are all part of the "medical equipment" industry.

Semler Scientific vs. Its Competitors

Semler Scientific (NASDAQ:SMLR) and CONMED (NYSE:CNMD) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, media sentiment, risk, institutional ownership, earnings, analyst recommendations, profitability and valuation.

CONMED has higher revenue and earnings than Semler Scientific. Semler Scientific is trading at a lower price-to-earnings ratio than CONMED, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Semler Scientific$56.29M10.35$40.90M-$2.61-16.31
CONMED$1.31B1.17$132.42M$3.8012.98

Semler Scientific currently has a consensus price target of $89.00, indicating a potential upside of 109.11%. CONMED has a consensus price target of $62.20, indicating a potential upside of 26.09%. Given Semler Scientific's stronger consensus rating and higher possible upside, research analysts clearly believe Semler Scientific is more favorable than CONMED.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Semler Scientific
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
3.33
CONMED
0 Sell rating(s)
4 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.20

In the previous week, Semler Scientific had 8 more articles in the media than CONMED. MarketBeat recorded 12 mentions for Semler Scientific and 4 mentions for CONMED. CONMED's average media sentiment score of 0.76 beat Semler Scientific's score of 0.51 indicating that CONMED is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Semler Scientific
1 Very Positive mention(s)
3 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
CONMED
2 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Semler Scientific has a beta of 1.39, indicating that its stock price is 39% more volatile than the S&P 500. Comparatively, CONMED has a beta of 1.2, indicating that its stock price is 20% more volatile than the S&P 500.

49.4% of Semler Scientific shares are owned by institutional investors. 30.2% of Semler Scientific shares are owned by insiders. Comparatively, 3.1% of CONMED shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

CONMED has a net margin of 9.02% compared to Semler Scientific's net margin of -60.69%. Semler Scientific's return on equity of 19.75% beat CONMED's return on equity.

Company Net Margins Return on Equity Return on Assets
Semler Scientific-60.69% 19.75% 15.47%
CONMED 9.02%14.36%5.86%

Summary

Semler Scientific beats CONMED on 11 of the 17 factors compared between the two stocks.

Get Semler Scientific News Delivered to You Automatically

Sign up to receive the latest news and ratings for SMLR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SMLR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SMLR vs. The Competition

MetricSemler ScientificMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$586M$6.63B$5.56B$9.26B
Dividend YieldN/A1.20%4.23%4.03%
P/E Ratio-16.4025.4028.5819.56
Price / Sales10.3586.75434.47183.65
Price / Cash10.1120.3636.0257.93
Price / Book1.714.618.165.58
Net Income$40.90M$174.76M$3.24B$257.82M
7 Day Performance0.57%-1.81%-0.64%-0.39%
1 Month Performance39.46%0.59%4.93%7.80%
1 Year Performance21.05%1.78%26.04%12.95%

Semler Scientific Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SMLR
Semler Scientific
2.5925 of 5 stars
$42.56
+0.9%
$89.00
+109.1%
+21.4%$586M$56.29M-16.40120
CNMD
CONMED
4.6933 of 5 stars
$51.86
-4.5%
$62.20
+19.9%
-28.7%$1.68B$1.31B13.653,900News Coverage
AORT
Artivion
2.3508 of 5 stars
$30.22
-1.6%
$32.40
+7.2%
+12.9%$1.31B$388.54M-60.441,600
CDRE
Cadre
2.9481 of 5 stars
$31.84
-1.2%
$37.50
+17.8%
-14.5%$1.31B$567.56M33.522,284
ESTA
Establishment Labs
1.5289 of 5 stars
$46.11
+5.9%
$52.40
+13.6%
-2.4%$1.26B$166.02M-14.871,018Analyst Forecast
TNDM
Tandem Diabetes Care
4.1794 of 5 stars
$16.25
-3.2%
$33.43
+105.7%
-67.9%$1.12B$982.95M-5.852,650Positive News
Analyst Revision
FNA
Paragon 28
N/A$13.11
+0.1%
$12.75
-2.7%
+70.9%$1.10B$256.18M-17.71343,000High Trading Volume
BLFS
BioLife Solutions
2.1527 of 5 stars
$21.81
-4.5%
$31.17
+42.9%
-0.1%$1.08B$82.25M-75.20440Positive News
LQDA
Liquidia Technologies
3.1978 of 5 stars
$12.45
+2.1%
$26.89
+116.0%
+16.6%$1.04B$14M-7.8850Trending News
Insider Trade
SSII
SS Innovations International
N/A$5.27
-1.3%
N/AN/A$1.03B$20.65M0.004
PLSE
Pulse Biosciences
3.715 of 5 stars
$15.81
+3.3%
$22.00
+39.2%
-22.0%$1.03B$700K0.00140

Related Companies and Tools


This page (NASDAQ:SMLR) was last updated on 7/16/2025 by MarketBeat.com Staff
From Our Partners